This is actually something we research in our lab. The simplest explanation is that fat cells serve as a depot for excess energy. If you consume excess calories they will be stored in fat cells, and the fat cells grow larger. If fat cells grow too large they become dysfunctional and release inflammatory signals to reduce insulin sensitivity, thus restricting further nutrient uptake and growth. Pushed too far, over-sized fat cells can become dysfunctional, perhaps necrotic, and inflammatory to a degree that they affect other tissues, leading to many of the co-pathologies seen with obesity.
TZD drugs, and similar treatments, basically tell fat cells to replicate, so instead of having one over-sized dysfunctional fat cell you could have two smaller healthier fat cells. Of course you still have the same amount of actual fat, but each cell is more metabolically healthy and so you avoid a lot of the inflammation and pathology associated with obesity. The ability to do this naturally, and the initial number of fat cells, seems to be somewhat different for each person, which is why there are those who are morbidly obese but seemingly healthy while at the same time there are more slender people with insulin resistance and such.
To some extent this reasearch focuses on how to create a benign obesity phenotype, since preventing or reversing obesity seems to be less likely at the moment. TZDs also have some pretty bad side effects if used too long, so (as with most drugs) they're good as a short term treatment to improve metabolic health to make initial fat loss easier, after which the individual can continue without drugs. But most people start the drugs, feel better, and think they can just keep on indefinitely with the drugs.
Really interesting. Thanks for posting that, James.
Does the weight gain from TZD cause a certain kind of subcutaneous fat redistribution to the body (i.e. upper body fat shifts to lower body)? From what I understand, apple, box, or V shapes, especially in women, are due to a lack of fat cells within the body, physiologically making them more prone to diabetes, etc. Supposedly the abdomen fat cells are the only subcutaneous fat cells that cannot multiply, so once there are enough fat cells within the body, there will be less inflammation excreted from over-filled fat cells within the abdomen. Therefore, does the subcutaneous weight gain from TZD change the body shape of subjects? It'd be interesting to know as I wonder if it could potentially prevent any future diabetic or insulin resistant diseases in those who are naturally born with apple, square, or v-shaped bodies, as well as hormonal imbalance within women of such a shape, or those whose health has declined as a result of the mechanical removal of fat. Hope I'm being clear.
Edited by JBForrester, 10 January 2013 - 02:37 AM.